JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FEINSTONE, W. H.
Right arrow Articles by WILLIAMS, R. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by FEINSTONE, W. H.
Right arrow Articles by WILLIAMS, R. D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 89, Issue 2, 153-166, 1947
Copyright © 1947 by American Society for Pharmacology and Experimental Therapeutics


STUDIES IN CHEMOTHERAPY OF TUBERCULOSIS

II. Activity In Vitro Of a Related Series of Ethers and Arylamines

W. HARRY FEINSTONE 1, HARRIS L. FRIEDMAN 1, MARY V. ROTHLAUF 1, ANNA M. KELLY 1, and ROGER D. WILLIAMS 1

1 Research Laboratories, Pyridium Corporation, Yonkers, New York

2-Butoxy 5-aminopyridine exerts high and specific bacteriostatic action on Mycobacteria.

Variations in the structure of this compound indicate that:

1. isosteres retain activity;

2. the number of carbon atoms in the alkoxy group is optimally 4 to 6;

3. cyclic substitutions in the alkoxy linkage diminish activity; other substitutions in the alkoxy group that tend to increase the molecular weight of the compound or which involve branched chains also result in compounds of greatly diminished activity;

4. in general, only specific isomers are active;

5. nuclear substitutions result in diminution of activity;

6. the ether linkage of the alkoxy group may be replaced by alkyl, in the benzene isostere series, without a serious loss in activity;

7. the amino group is essential to activity;

8. when the amino group is substituted by certain inorganic or acyclic substituents, activity is diminished but not abolished;

9. the amino group may be substituted by acyl, sodium formaldehyde bisulfite, sodium formaldehyde sulfoxylate and certain other aldehydic groupings without serious loss in activity in most cases. This type of substitution results in compounds with decreased toxicity in the pyridine series, but does not produce a marked change in toxicity in the series of benzene isosteres.

The pharmacological and experimental therapeutic activity of several of the most effective and least toxic of the compounds should be investigated.

Submitted on November 15, 1946







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1947 by the American Society for Pharmacology and Experimental Therapeutics.